-
2022-500424-30-00
4
2022-12-28
Parkinson’s disease
-
2024-516556-17-00
5
2022-12-12
Intermediate and high-risk prostate cancer
-
2022-500445-24-00
5
2022-11-30
Moderately to Severely Active Systemic Lupus Erythematosus
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2023-505904-41-00
5
2022-11-17
Hereditary Angioedema Type I or II
-
2024-516988-87-00
4
2022-11-09
Chronic Inducible Urticaria
-
2022-500350-42-01
10
2022-11-07
Prevention of RSV
-
2022-500079-30-00
5
2022-11-03
IgA Nephropathy
-
2024-513658-31-00
4
2022-08-08
Idiopathic Sudden Sensorineural Hearing Loss
-
2023-508734-34-00
10
2022-06-30
Pulmonary Arterial Hypertension (PAH)
-
2023-505455-44-00
9
2022-06-29
Solid tumours
-
2023-507569-24-00
4
2022-06-20
Myocardial Infarction, Acute
Heart Failure, Left Sided
-
2023-509668-11-00
6
2022-06-15
Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.
-
2023-508755-39-00
5
2022-05-16
Triple Negative Breast Cancer
-
2023-508645-40-00
10
2022-05-10
Bullous Pemphigoid (BP)
-
2023-509141-12-00
4
2022-04-28
Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH
-
2024-514372-40-00
5
2022-04-12
Anterior ST-Elevation Myocardial Infarction
-
2024-511560-93-00
5
2022-03-29
Schizophrenia
-
2024-514336-24-00
5
2022-03-24
Familial Chylomicronemia Syndrome (FCS)
-
2024-510696-38-00
5
2022-03-08
Severe Hypertriglyceridemia.
-
2023-506004-93-00
4
2022-03-01
Ulcerative Colitis (UC)
-
2024-518090-34-00
5
2022-02-07
Acute Coronary Syndrom (ACS)
-
2023-509233-39-00
4
2022-01-20
Moderately to Severely Active Ulcerative Colitis
-
2023-509018-12-00
5
2021-12-17
Moderately to severely active Ulcerative Colitis (UC)